Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10467024rdf:typepubmed:Citationlld:pubmed
pubmed-article:10467024lifeskim:mentionsumls-concept:C0007082lld:lifeskim
pubmed-article:10467024lifeskim:mentionsumls-concept:C0530993lld:lifeskim
pubmed-article:10467024lifeskim:mentionsumls-concept:C0152013lld:lifeskim
pubmed-article:10467024lifeskim:mentionsumls-concept:C0010803lld:lifeskim
pubmed-article:10467024lifeskim:mentionsumls-concept:C1708096lld:lifeskim
pubmed-article:10467024lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:10467024lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:10467024pubmed:issue5lld:pubmed
pubmed-article:10467024pubmed:dateCreated1999-10-21lld:pubmed
pubmed-article:10467024pubmed:abstractTextFifty patients with adenocarcinoma of the lung were enrolled in this study, including 20 patients with recurrence and 30 patients without recurrence 1 year after surgery. Serial serum levels of cytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen (CEA) were measured before the operation and 1 week, 1 month, 3 months, 6 months, 9 months, and 12 months after surgery for the early detection of recurrence. The results revealed that the mean serum values of either CYFRA 21-1 or CEA were significantly higher until 9 and 12 months after surgery in the 20 patients with recurrent adenocarcinoma compared with the 30 patients without recurrent adenocarcinoma. We conclude that CYFRA 21-1 is not a better marker than CEA for early prediction of adenocarcinoma. We conclude that CYFRA 21-1 is not a better marker than CEA for early prediction of adenocarcinoma recurrence in lung.lld:pubmed
pubmed-article:10467024pubmed:languageenglld:pubmed
pubmed-article:10467024pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10467024pubmed:citationSubsetIMlld:pubmed
pubmed-article:10467024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10467024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10467024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10467024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10467024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10467024pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10467024pubmed:statusMEDLINElld:pubmed
pubmed-article:10467024pubmed:issn0341-2040lld:pubmed
pubmed-article:10467024pubmed:authorpubmed-author:KaoC HCHlld:pubmed
pubmed-article:10467024pubmed:authorpubmed-author:YimYYlld:pubmed
pubmed-article:10467024pubmed:authorpubmed-author:DingH JHJlld:pubmed
pubmed-article:10467024pubmed:authorpubmed-author:HsiehJ FJFlld:pubmed
pubmed-article:10467024pubmed:issnTypePrintlld:pubmed
pubmed-article:10467024pubmed:volume177lld:pubmed
pubmed-article:10467024pubmed:ownerNLMlld:pubmed
pubmed-article:10467024pubmed:authorsCompleteYlld:pubmed
pubmed-article:10467024pubmed:pagination333-7lld:pubmed
pubmed-article:10467024pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:meshHeadingpubmed-meshheading:10467024...lld:pubmed
pubmed-article:10467024pubmed:year1999lld:pubmed
pubmed-article:10467024pubmed:articleTitleCytokeratin fragment 19 (CYFRA 21-1) and carcinoembryonic antigen for early prediction of recurrence of lung adenocarcinoma.lld:pubmed
pubmed-article:10467024pubmed:affiliationDepartment of Nuclear Medicine, Taichung Veterans General Hospital, Taiwan.lld:pubmed
pubmed-article:10467024pubmed:publicationTypeJournal Articlelld:pubmed